Samsung is investing 240 trillion won in new investments over the next three years to prepare for the profound transformation of industrial, international, and social structures in the post-COVID-19 era, placing a bet on its survival.

Samsung Electronics and its major affiliates announced plans on the 24th to: △ expand investment to secure leadership in strategic businesses; △ create jobs/opportunities for future generations; and △ foster an ecosystem where everyone can grow together.

Samsung plans to expand its investment scale to a total of 240 trillion won over the next three years, with 180 trillion won of that to be invested domestically.

This investment is effectively seen as a survival strategy, as it is nearly impossible to recover once the semiconductor industry loses its competitiveness.

The company plans to solidify its "absolute advantage" in memory by investing in the development of next-generation product solutions, including DRAMs under 14 nanometers and NAND flash with 200 layers or more.

System semiconductors will invest 171 trillion won by 2030.

System semiconductors will enter early mass production of 3nm or less by developing new structures using new technologies such as GAA, and will support the expansion of the system semiconductor business from the existing mobile-focused to new applications such as AI and data centers and the creation of a related ecosystem.

Bio plans to write a second semiconductor myth by strengthening its CDMO (Contract Development Manufacturing Organization) and biosimilars.

Samsung has completed three CDMO plants in just nine years since starting its bio business, and is currently building one. Upon completion of Plant 4, Samsung BioLogics will become the world's overwhelming leader in the CDMO field with a production capacity of 620,000 liters.

Samsung Biologics and Samsung Bioepis will continue their aggressive investment strategy going forward. They will expand their absolute dominance in the CDMO sector by building Plants 5 and 6, securing their role as a global biopharmaceutical production hub. They will also enter the next-generation therapeutics CDMO market, including vaccines and cell/gene therapies, in addition to biopharmaceuticals.

In next-generation communications, we plan to continue strengthening our 5G leadership beyond 5G/6G.

Samsung plans to secure key personnel and expand R&D investments related to next-generation communication network technologies, such as virtualized networks and open base stations, while also pursuing new business areas and expanding its product portfolio to grow into a leader in the next-generation network business, including communication equipment and next-generation network operation solutions, in addition to its existing RAN/Core business.

In addition, we plan to strengthen our leadership in the Fourth Industrial Revolution, including AI, robots, and supercomputers.

In addition, Samsung plans to directly hire 40,000 people over the next three years. Furthermore, investment and production are expected to create 560,000 new jobs.

We will also expand support for basic science and core technology R&D, strengthen industry-academia cooperation, and upgrade the manufacturing capabilities of small and medium-sized enterprises through smart factory programs.

Here, we plan to strengthen the safety net for our partners by expanding our mutually beneficial cooperation program, and to redefine Samsung's CSR direction and develop specific measures to ensure that Samsung's CSR activities contribute more substantially to our society.